BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways

Xiaoxia Qi, Teng-Guo Li, Jing Hao, +6

Proceedings of the National Academy of Sciences

Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand

Kazuko Murata, Naoto Ishii, Hiroshi Takano, +5

The Journal of Experimental Medicine

Clinicopathologic Characteristics and Prognosis of Breast Cancer Patients Associated with Pregnancy and Lactation: Analysis of Case‐Control Study in Japan

Tsunehiro Ishida, Takao Yokoe, Fujio Kasumi, +14

Japanese Journal of Cancer Research

Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA

Shigeto Miura, Toshikazu Takeshita, Hironobu Asao, +9

Molecular and Cellular Biology

Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan

Manami Inoue, Kazuo Tajima, Mitsuhiro Mizutani, +6

Cancer Letters

NutritionBreast Cancer RecurrencePreventive MedicineCancer EpidemiologyCancer Risk +9

Mannose-Binding Lectin (MBL)-Associated Serine Protease (MASP)-1 Contributes to Activation of the Lectin Complement Pathway

Minoru Takahashi, Daisuke Iwaki, Kazuko Kanno, +8

The Journal of Immunology

Protein SecretionInnate Immune SystemGlycobiologyImmunologyImmune Regulation +17

ORIGINAL CONTRIBUTIONS

Keun‐Young Yoo, Kazuo Tajima, Tetsuo Kuroishi, +4

American Journal of Epidemiology

NutritionPreventive MedicineCancer EpidemiologyCancer RiskEpidemiology Of Cancer +11

Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women

Kaoru Hirose, Toshiro Takezaki, Nobuyuki Hamajima, +2

International Journal of Cancer

NutritionNutritional EpidemiologyDietary ExposurePublic Health NutritionGynecology +17

Association ofp53 codon arg72pro andp73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of japanese breast cancer

Xin‐En Huang, Nobuyuki Hamajima, Nobuyuki Katsuda, +8

Breast Cancer

Tumor BiologyCancer RiskCancer EpidemiologyGenetic PolymorphismsMedicine +11

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, +14

Breast Cancer Research and Treatment

Breast OncologyMedicinePhase Iii TrialClinical TrialsBreast Cancer +6